Ocata therapeutics is a clinical stage biopharma company developing regenerative medicine and cell therapy technologies. Ocata’s most advanced products are in clinical trials for the treatment of Stargardt’s macular degeneration, dry age-related macular degeneration and myopic macular degeneration.